Compare FDA BA/BE data integrity and FDA electronic systems Q&A
How to read this page
- How they are linked says why these two documents are connected. Links explained
- Side by side places facts from each record together, so you can see status, weight and dates at a glance.
- It does not compare content. It does not say which is stricter. Read the official texts for that.
How they are linked
- FDA BA/BE data integrity is related to FDA electronic systems Q&A · Source Unverified link
Side by side
| FDA BA/BE data integrity | FDA electronic systems Q&A | |
|---|---|---|
| Authority | FDA | FDA |
| Legal weight | Guidance & Q&A | Guidance & Q&A |
| Status | Draft | Final |
| Last verified | Not yet | Not yet |
| Summary | Draft FDA guidance for applicants and testing sites on achieving and maintaining data integrity in the clinical and bioanalytical parts of bioavailability and bioequivalence studies. | FDA recommendations for sponsors, clinical investigators, review boards and contract research organisations on using electronic systems, records and signatures in clinical investigations, and when FDA treats them as equivalent to paper records and handwritten signatures. |
| Lifecycle |
|
|
| Source | Official text Source: FDA. Public domain. | Official text Source: FDA. Public domain. |
These facts are placed side by side from each record. This page does not say which is stricter or whether requirements differ. Read the official texts.